Matches in DBpedia 2016-04 for { <http://dbpedia.org/resource/Executive_Order_13139> ?p ?o }
Showing triples 1 to 34 of
34
with 100 triples per page.
- Executive_Order_13139 abstract "Executive Order 13139— entitled Improving Health Protection of Military Personnel Participating in Particular Military Operations — as an executive order (EO) issued by U.S. President Bill Clinton on 30 September 1999. It outlines the conditions under which Investigational New Drug (IND) and off-label pharmaceuticals can be administered to U.S. service members. An “off-label\" indication is a use of a drug in a manner (or for a condition) other than that for which they were originally licensed. EO13139 provides the US Secretary of Defense guidance regarding the provision of IND products or products unapproved for their intended use as antidotes to chemical, biological, or radiological weapons; stipulates that the U.S. government will administer products approved by the U.S. Food and Drug Administration only for their intended use; provides the circumstances and controls under which IND products may be used.It also stipulates that to administer an IND product, informed consent must be obtained from individual service members. However, the President of the United States may waive informed consent (at the request of the Secretary of Defense and only the Secretary of Defense) if:Informed consent is not feasibleInformed consent is contrary to the best interests of the service memberObtaining informed consent is not in the best interests of national security.".
- Executive_Order_13139 wikiPageExternalLink 99-26078.pdf.
- Executive_Order_13139 wikiPageID "44498064".
- Executive_Order_13139 wikiPageLength "1777".
- Executive_Order_13139 wikiPageOutDegree "14".
- Executive_Order_13139 wikiPageRevisionID "666239100".
- Executive_Order_13139 wikiPageWikiLink Bill_Clinton.
- Executive_Order_13139 wikiPageWikiLink CBRN_defense.
- Executive_Order_13139 wikiPageWikiLink Category:1999_in_law.
- Executive_Order_13139 wikiPageWikiLink Category:Biological_warfare.
- Executive_Order_13139 wikiPageWikiLink Category:Executive_orders_of_Bill_Clinton.
- Executive_Order_13139 wikiPageWikiLink Category:Legal_history_of_the_United_States.
- Executive_Order_13139 wikiPageWikiLink Defence_minister.
- Executive_Order_13139 wikiPageWikiLink Executive_order.
- Executive_Order_13139 wikiPageWikiLink Federal_Register.
- Executive_Order_13139 wikiPageWikiLink Food_and_Drug_Administration.
- Executive_Order_13139 wikiPageWikiLink Informed_consent.
- Executive_Order_13139 wikiPageWikiLink Investigational_New_Drug.
- Executive_Order_13139 wikiPageWikiLink Off-label_use.
- Executive_Order_13139 wikiPageWikiLink President_of_the_United_States.
- Executive_Order_13139 wikiPageWikiLinkText "Executive Order 13139".
- Executive_Order_13139 wikiPageUsesTemplate Template:U.S._biological_defense.
- Executive_Order_13139 wikiPageUsesTemplate Template:Wikisource.
- Executive_Order_13139 subject Category:1999_in_law.
- Executive_Order_13139 subject Category:Biological_warfare.
- Executive_Order_13139 subject Category:Executive_orders_of_Bill_Clinton.
- Executive_Order_13139 subject Category:Legal_history_of_the_United_States.
- Executive_Order_13139 comment "Executive Order 13139— entitled Improving Health Protection of Military Personnel Participating in Particular Military Operations — as an executive order (EO) issued by U.S. President Bill Clinton on 30 September 1999. It outlines the conditions under which Investigational New Drug (IND) and off-label pharmaceuticals can be administered to U.S. service members. An “off-label\" indication is a use of a drug in a manner (or for a condition) other than that for which they were originally licensed.".
- Executive_Order_13139 label "Executive Order 13139".
- Executive_Order_13139 sameAs Q19104080.
- Executive_Order_13139 sameAs m.012c5knq.
- Executive_Order_13139 sameAs Q19104080.
- Executive_Order_13139 wasDerivedFrom Executive_Order_13139?oldid=666239100.
- Executive_Order_13139 isPrimaryTopicOf Executive_Order_13139.